Updates are available Correction dated 2024-04-18
Click to view Correction: https://doi.org/10.1007/s00262-024-03668-8
-
Authors
Li, Ke
Xu, Jing
Wang, Jing
Lu, Chong
Dai, Yilin
Dai, Qing
Zhang, Wang
Xu, Congjian
Wu, Shu
-
Funding
Funding for this research was provided by:
National Key R&D Program of China (2016YFC1303100)
National Key R&D Program of China (2016YFC1303102)
Shanghai Shenkang Hospital Development Center (SHDC12018X13)
Shanghai Municipal Health and Family Planning Commission (2018BR26)
Shanghai Science and Technology Commission (18140902502)
Shanghai Science and Technology Commission (18411963300)
- License Information
-
More Information
Article History
Received: 22 February 2021
Accepted: 2 September 2022
First Online: 27 September 2022
Change Date: 18 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00262-024-03668-8
Declarations
:
: No conflicts.
: All animal experiments were performed according to the Ethics Committee of Department of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University (Shanghai, China). The applied of human T cells and the human ovarian cancer tissues was approved by the patients and the Ethics Committee of Department of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University (Shanghai, China).
: Female NCG mice were purchased from GemPharmatech Co., Ltd. (Jiangsu, China).
